Chunyu Wu

Merck & Co., Inc., Rahway, NJ, USA (United States)

Agricultural and Biological SciencesMedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Engineering of new-to-nature ribosomally synthesized and post-translationally modified peptide natural products”.

Engineering of new-to-nature ribosomally synthesized and post-translationally modified peptide natural products

Current Opinion in Biotechnology(2021)10.1016/j.copbio.2020.12.022

N/A

0DataRank · unranked

63 citations

Wilfred A. van der Donk, Chunyu Wu

Improved production of class I lanthipeptides in Escherichia coli

Chemical Science(2023)10.1039/d2sc06597e

N/A

0DataRank · unranked

17 citations

Chunyu Wu, Emily K. Desormeaux, Raymond Sarksian, Wilfred A. van der Donk, Hyunji Lee

Investigation into the mechanism of action of the antimicrobial peptide epilancin 15X

Frontiers in Microbiology(2023)10.3389/fmicb.2023.1247222

N/A

0DataRank · unranked

6 citations

B. Alexis Lower, Ryan Moreira, Darian Dorantes, Tung Le, Constantin Giurgiu +3 more

Exposure and resistance to lantibiotics impact microbiota composition and function

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.30.573728

N/A

0DataRank · unranked

4 citations

Cody G. Cole, Huaiying Lin, Chunyu Wu, Fidel Haro, Emma McSpadden +3 more